Patient Compliance with Proton Pump Inhibitor Therapy in an Otolaryngology Practice

Abstract

Objectives:

Proton pump inhibitors (PPIs) are used for the treatment of numerous otolaryngological disorders. It has been demonstrated that administration of the medication 15 to 45 minutes before a meal optimizes acid suppression. The rate of compliance with optimal PPI dosage patterns in an otolaryngology practice is not known. We sought to determine the rate of PPI compliance in patients seen in an otolaryngology practice.

Methods:

We conducted an interview at a tertiary voice and swallowing center of 200 consecutive patients who were taking PPIs.

Results:

Overall, 54% of patients took their PPI in an optimal manner. The rate of compliance was significantly higher for patients who had their PPI prescribed by an otolaryngologist (62%) than for patients whose PPI was prescribed by a non-otolaryngologist (40%).

Conclusions:

Nearly half of all patients seen at a voice and swallowing center were not compliant with optimal PPI usage. This percentage is similar to that found for other long-term medications. Patient education can lead to higher rates of compliance, improved acid control, and possibly improved treatment outcomes.

Keywords

gastroesophageal reflux laryngopharyngeal reflux proton pump inhibitor reflux

Get full access to this article

View all access options for this article.

References

http://www.cdc.gov/nchs/data/ad/ad387.pdf.

Ford

. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534–40.

Cohen

Bach

Postma

Koufman

. Clinical manifestations of laryngopharyngeal reflux. Ear Nose Throat J 2002;81 (suppl 2):19–23.

Hatlebakk

Katz

Camacho-Lobato

Castell

. Proton pump inhibitors: Better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther 2000;14:1267–72.

Barrison

Jarboe

Weinberg

Nimmagadda

Sullivan

Wolfe

. Patterns of proton pump inhibitor use in clinical practice. Am J Med 2001;111:469–73.

Gunaratnam

Jessup

Inadomi

Lascewski

. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23:1473–7.

Robinson

Horn

. Clinical pharmacology of proton pump inhibitors: What the practising physician needs to know. Drugs 2003;63:2739–54.

Besancon

Simon

Sachs

Shin

. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J Biol Chem 1997;272:22438–46.

Wolfe

Sachs

. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000;118 (suppl 1):S9-–S31.

10.

Koufman

Aviv

Casiano

Shaw

. Laryngopharyngeal reflux: Position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32–5.

11.

Park

Hicks

Khandwala

. Laryngopharyngeal reflux: Prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230–8.

12.

Kimmel

Chen

Price

. The influence of patient adherence on anticoagulation control with warfarin: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 2007;167:229–35.

13.

Koneru

Shishov

Ware

. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum 2007;57:1000–6.

14.

Frick

Gal

Lane

Sewell

. Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care STDS 1998;12:463–70.

15.

Humayun

Hoff

Robinson

Gunaratnam

. Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease. Otolaryngol Head Neck Surg 2007;137:936–41.